DREYER SCOTT (EVP & Chief Commercial Officer) sold 14.5% of their position (17.60K shares) of COLLEGIUM PHARMACEUTICAL, INC on the open market
Open‑market sale worth $847.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/10/2025ACC: 0001746251-25-000004
Officer· EVP & Chief Commercial Officer
Since Jul 2018
-17.60K
Net shares
Net seller
$847.9K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
17.60K acquired · 35.20K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+17.60K
Price / share
$15.90
Trade value
$279.84K
% of position
17.0%
12/8/2025
103.61K→121.21K
Common Stock
Direct
Shares
−11.13K
Price / share
$47.89
Trade value
$532.77K
% of position
9.2%
12/8/2025
121.21K→110.09K
Common Stock
Direct
Shares
−6.47K
Price / share
$48.66
Trade value
$315.08K
% of position
5.9%
12/8/2025
110.09K→103.61K
Total
Net shares
+0.00
Net value
-$568.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/8/2025 | M · Option Exercise | +17.60K | $15.90 | $279.84K | 17.0% | 103.61K | 121.21K |
| Common Stock Direct | 12/8/2025 | S · Sale | −11.13K | $47.89 | $532.77K | 9.2% | 121.21K | 110.09K |
| Common Stock Direct | 12/8/2025 | S · Sale | −6.47K | $48.66 | $315.08K | 5.9% | 110.09K | 103.61K |
| Total | +0.00 | -$568.02K | ||||||
Derivative Transactions1
Stock Option (Right to Purchase)
Direct
Converts to
Common Stock
17.60K shares
Shares
−17.60K
Strike price
15.90
Held after
0.00
Exercisable
—
12/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase) Direct | Common Stock17.60K shares | 12/8/2025 | M · Option Exercise | −17.60K | 15.90 | — | 0.00 |